Russo D, Chazenbalk G D, Nagayama Y, Wadsworth H L, Seto P, Rapoport B
Thyroid Molecular Biology Unit, Veterans Administration Medical Center, University of California, San Francisco 94121.
Mol Endocrinol. 1991 Nov;5(11):1607-12. doi: 10.1210/mend-5-11-1607.
The most widely held model for the human TSH receptor is of holoreceptor of 80 kDa with two subunits of approximately 50 and 30 kDa linked by disulfide bridges, with the former subunit containing the major hormone-binding site. We reexamined this model by covalently cross-linking radiolabeled TSH to the recombinant human TSH receptor stably expressed in Chinese hamster ovary (CHO) cells. When cross-linking was performed after the preparation of CHO membranes, analysis of hormone-receptor complexes under reducing and nonreducing conditions provided results supporting the two-subunit TSH receptor model. In contrast, however, cross-linking of TSH to the TSH receptor in intact CHO cells before membrane preparation revealed, even under reducing conditions, an approximately 100-kDa receptor as well as an approximately 54-kDa hormone-binding subunit. The approximately 100-kDa holoreceptor size is consistent with the size of the TSH receptor, as predicted from its derived amino acid sequence. The proportions of the approximately 100-kDa TSH receptor and the 54-kDa fragment varied in different experiments, suggesting the occurrence of proteolytic cleavage. Cross-linking of radiolabeled TSH to intact cells expressing a mutant TSH receptor (TSHR-D1) lacking amino acids 317-366 localized the proteolytic cleavage site to just up-stream of amino acid residue 317. In summary, the present data obtained by cross-linking TSH to recombinant human TSH receptors in intact cells provides evidence that the receptor exists in vivo as an approximately 100-kDa glycoprotein with a single polypeptide chain with intramolecular disulfide bridges.(ABSTRACT TRUNCATED AT 250 WORDS)
目前关于人类促甲状腺激素(TSH)受体最广泛认可的模型是一个80 kDa的全受体,由两个亚基通过二硫键相连,这两个亚基分子量分别约为50 kDa和30 kDa,前一个亚基包含主要的激素结合位点。我们通过将放射性标记的TSH与稳定表达于中国仓鼠卵巢(CHO)细胞中的重组人TSH受体进行共价交联,重新审视了这一模型。当在制备CHO细胞膜后进行交联时,在还原和非还原条件下对激素-受体复合物的分析结果支持了两亚基TSH受体模型。然而,与之形成对比的是,在制备细胞膜之前将TSH与完整CHO细胞中的TSH受体进行交联,结果显示,即使在还原条件下,也存在一个约100 kDa的受体以及一个约54 kDa的激素结合亚基。约100 kDa的全受体大小与根据TSH受体推导的氨基酸序列预测的大小一致。在不同实验中,约100 kDa的TSH受体和54 kDa片段的比例有所不同,提示存在蛋白水解切割。将放射性标记的TSH与表达缺失氨基酸317 - 366的突变型TSH受体(TSHR - D1)的完整细胞进行交联,将蛋白水解切割位点定位在氨基酸残基317的上游。总之,通过将TSH与完整细胞中的重组人TSH受体进行交联所获得的当前数据表明,该受体在体内以一种约100 kDa的糖蛋白形式存在,具有一条含分子内二硫键的单多肽链。(摘要截选至250字)